I hope some of you had the chance to go downtown for First Staturday this weekend. With the weather and the people, it was fabulous!
And speaking of fabulous, I have nearly 90 RSVP’s for BioBeers this Thursday. It is gong to be a fabulous time so be there or be square, you nerd.
In other news of interest, I saw a press release just an hour ago from ImQuest in the PR Newswire. Looks like their HIV pyrimidinedione inhibitor, IQP-0410, has a “highly positive” saftey profile, suitable for use in pregnant women.
“The data presented today indicate that IQP-0410 may represent a next generation HIV drug with a highly unique mechanism of action and an excellent safety profile,” said Dr. Buckheit, Executive Vice President and Chief Scientific Officer.
Since they will be at BioBeers again, make sure you stop and ask thme about it and congratulate them on what could be a blockbuster drug (fingers crossed).
Also of note, International Stem Cells, parent of Walkersville-based LifeLine Cell Technology, had a Press Release last week stating they are planning pre-clinical trials aimed at applying its laboratory-grown human corneal epithelial cells to improve photorefractive keratectomy (PRK), a form of corrective laser eye surgery.
All kinds of good stuff going on this week. Anyone else have news to share?

All content on this site is copyright under Creative Commons Attribution - Share Alike license.










FiberCell Systems